Results 271 to 280 of about 4,434,775 (339)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Usefulness of the Mini Nutritional Assessment in the screening of sarcopenia in a sample of institutionalized older persons: A cross-sectional study

open access: gold
Esmeralda Garza-Santiago   +6 more
openalex   +2 more sources

HIV care indicators during the COVID-19 pandemic in relation to pre-pandemic care patterns among people with HIV in North Carolina. [PDF]

open access: yesAIDS Care
Maierhofer CN   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy